NEW YORK and TEL AVIV, Israel, Jan. 5, 2006 (PRIMEZONE) -- BrainStorm Cell Therapeutics, Inc. (OTCBB:BCLI) will be one of the featured companies on the Corporate Strategies Radio Show, airing Sunday night from 9:00-11:00 pm EST. Dr. Rob Shorr, member of the board of directors of BrainStorm Cell Therapeutics, Inc. will be discussing the company's progress in the development of stem cell treatments for Parkinsons and other neuro degenerative diseases.
Dr. Shorr is a respected member of biotechnology and pharmaceutical science community, having participated in the financing, business growth and development of multiple companies. His expertise varies from technological innovation to strategic planning and implementation of research and business development, to the founding, financing and guiding of full commercialization of biotechnology ventures. Dr. Shorr has published more than 100 scientific/technical articles and has more than 100 inventions issued or patent-pending worldwide, many of them commercialized. He holds a Bachelor of Science in Biology from the State University of Buffalo, a D.I.C., from the University of London Imperial College of Science and Technology, and a Ph.D. from the University of London.
The Corporate Strategies radio broadcast airs every Sunday evening on 400 different stations nationwide and is known for providing insider perspective on emerging and established companies.